Paratek (formerly Transcept Pharmaceuticals)
IPOKing of Prussia, United States · Founded 1996 · $1.6B raised
- Headquarters
- King of Prussia, Pennsylvania
- Employees
- 51–200
- Founded
- 1996
- Business Model
- B2B
- Total Funding
- $1.6B
- Last Round
- $1.6B Venture RoundJan 2008
- Rounds
- 2
About
Paratek Pharmaceuticals is a biopharmaceutical company developing antibiotic therapies based on novel tetracycline chemistry.
Summary
Paratek (formerly Transcept Pharmaceuticals) is a Biotech company based in King of Prussia, United States, founded in 1996. It has raised $1.6B in total across 2 rounds, most recently a $1.6B Venture Round round in Jan 2008. Investors include Novo Holdings and CBC Group.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2008
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...